Elena Surkova1, Denisa Muraru2, Davide Genovese3, Patrizia Aruta3, Chiara Palermo3, Luigi P Badano4. 1. Department of Cardiac, Thoracic and Vascular Sciences, University of Padua School of Medicine, Padua, Italy; Department of Echocardiography, Cardiac Division, Royal Brompton Hospital, London, United Kingdom. 2. Department of Cardiac, Thoracic and Vascular Sciences, University of Padua School of Medicine, Padua, Italy; Istituto Auxologico Italiano, IRCCS, and University of Milano-Bicocca, Milan, Italy. 3. Department of Cardiac, Thoracic and Vascular Sciences, University of Padua School of Medicine, Padua, Italy. 4. Department of Cardiac, Thoracic and Vascular Sciences, University of Padua School of Medicine, Padua, Italy; Istituto Auxologico Italiano, IRCCS, and University of Milano-Bicocca, Milan, Italy. Electronic address: lpbadano@gmail.com.
Abstract
BACKGROUND: The study aimed (1) to assess the prognostic value of three-dimensional echocardiography (3DE) derived right ventricular (RV) ejection fraction (EF) and (2) to evaluate relative prognostic importance of reduced and preserved left ventricular (LV) EF and RVEF to predict all-cause mortality and cardiac death in a large cohort of patients with cardiac diseases. METHODS: LV and RV volumes and EF were assessed by 3DE in 394 patients with various cardiovascular diseases. Patients were divided into four groups: (1) normal LVEF (≥50%) and normal RVEF (≥45%), n = 183; (2) reduced LVEF (<50%) and normal RVEF (≥45%), n = 75; (3) normal LVEF (≥50%) and reduced RVEF (<45%), n = 61; (4) reduced LVEF (<50%) and reduced RVEF (<45%), n = 75. The patients were followed up for 3.7 ± 1.1 years. RESULTS: Reduced 3DE-derived RVEF was associated with all-cause mortality (P < .0001). The four groups had significantly different survival (P < .0001). Both all-cause mortality and cardiac death in patients with reduced RVEF and normal LVEF were significantly higher than in those with reduced LVEF and normal RVEF (P = .0007 and P = .0091, respectively) and did not differ significantly from patients with reduced EF of both ventricles (P = .2198 and P = .0846, respectively). CONCLUSIONS: Reduced 3DE-derived RVEF was associated with all-cause mortality and cardiac death in patients with various cardiovascular diseases. Impairment of RVEF carried a significantly higher risk of mortality independent of LVEF.
BACKGROUND: The study aimed (1) to assess the prognostic value of three-dimensional echocardiography (3DE) derived right ventricular (RV) ejection fraction (EF) and (2) to evaluate relative prognostic importance of reduced and preserved left ventricular (LV) EF and RVEF to predict all-cause mortality and cardiac death in a large cohort of patients with cardiac diseases. METHODS: LV and RV volumes and EF were assessed by 3DE in 394 patients with various cardiovascular diseases. Patients were divided into four groups: (1) normal LVEF (≥50%) and normal RVEF (≥45%), n = 183; (2) reduced LVEF (<50%) and normal RVEF (≥45%), n = 75; (3) normal LVEF (≥50%) and reduced RVEF (<45%), n = 61; (4) reduced LVEF (<50%) and reduced RVEF (<45%), n = 75. The patients were followed up for 3.7 ± 1.1 years. RESULTS: Reduced 3DE-derived RVEF was associated with all-cause mortality (P < .0001). The four groups had significantly different survival (P < .0001). Both all-cause mortality and cardiac death in patients with reduced RVEF and normal LVEF were significantly higher than in those with reduced LVEF and normal RVEF (P = .0007 and P = .0091, respectively) and did not differ significantly from patients with reduced EF of both ventricles (P = .2198 and P = .0846, respectively). CONCLUSIONS: Reduced 3DE-derived RVEF was associated with all-cause mortality and cardiac death in patients with various cardiovascular diseases. Impairment of RVEF carried a significantly higher risk of mortality independent of LVEF.
Authors: André Y Denault; Matthew P Aldred; Ali Hammoud; Yu Hao Zeng; William Beaubien-Souligny; Etienne J Couture; Stéphanie Jarry; Caroline E Gebhard; Stephane Langevin; Yoan Lamarche; Pierre Robillard Journal: Crit Care Explor Date: 2020-09-28
Authors: Jonathan D Stock; Eric S Rothstein; Scott E Friedman; Anthony S Gemignani; Salvatore P Costa; Andrew J Milbridge; Rui Zhang; Cynthia C Taub; Daniel J O'Rourke; Robert T Palac Journal: Front Cardiovasc Med Date: 2022-09-02
Authors: Pulkit Singh; Julian Haimovich; Christopher Reeder; Shaan Khurshid; Emily S Lau; Jonathan W Cunningham; Anthony Philippakis; Christopher D Anderson; Jennifer E Ho; Steven A Lubitz; Puneet Batra Journal: JMIR Med Inform Date: 2022-09-16
Authors: Elena Surkova; Attila Kovács; Márton Tokodi; Bálint Károly Lakatos; Béla Merkely; Denisa Muraru; Alessandro Ruocco; Gianfranco Parati; Luigi P Badano Journal: Circ Cardiovasc Imaging Date: 2021-09-30 Impact factor: 7.792